Publications by authors named "Rachel A Dahl"
Article Synopsis
- - The study investigates how negative biases against illicit drug users impact their treatment in hospitals, particularly among emergency providers who might show stronger biases due to the critical situations they face.
- - Researchers surveyed hospital staff through an online implicit association test and explicit bias survey, finding some differences in attitudes about drug users' deserving access to quality healthcare among different departments.
- - Results suggest that emergency and obstetrics/gynecology providers exhibit more explicit negative bias towards patients using drugs compared to other healthcare professionals, although the study's small sample size limits the conclusions that can be drawn.
Multiple sclerosis (MS) is a chronic demyelinating disorder of the central nervous system (CNS). Its corresponding animal model, experimental autoimmune encephalomyelitis (EAE), is widely used to understand disease pathogenesis and test novel therapeutic agents. However, existing methods to score EAE disease severity are subjective and often vary between individual researchers, making it difficult to translate findings across different studies.
View Article and Find Full Text PDFBackground: Despite the high prevalence of epidermal growth factor receptor (EGFR) overexpression in head and neck squamous cell carcinomas (HNSCCs), incorporation of the EGFR inhibitor cetuximab into the clinical management of HNSCC has not led to significant changes in long-term survival outcomes. Therefore, the identification of novel therapeutic approaches to enhance the clinical efficacy of cetuximab could lead to improved long-term survival for HNSCC patients. Our previous work suggests that EGFR inhibition activates the interleukin-1 (IL-1) pathway via tumor release of IL-1 alpha (IL-1α), although the clinical implications of activating this pathway are unclear in the context of cetuximab therapy.
View Article and Find Full Text PDF